Advertisement

Advertisement

Direct From ASCO

Information-Blocking Proposal Helps Protect Reproductive Health Information, Patient Preferences

ASCO  /  November 25, 2024

The Association for Clinical Oncology (ASCO) submitted comments to the Office of the National Coordinator for Health Information Technology in response to the Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability (HTI-2) proposed r...

Katherine Van Loon Named Editor-in-Chief of JCO Global Oncology

ASCO  /  November 25, 2024

Katherine Van Loon, MD, MPH, has been appointed as the next Editor-in-Chief of JCO Global Oncology (JCO GO). JCO GO is an online-only, open-access ASCO journal focusing on cancer research, care, and delivery in low-resource countries and settings. The journal aims to address the challenges faced b...

Global Cancer Care

18 Researchers and Mentors Selected for ASCO’s Inaugural International Clinical Research Scholars Program in Latin America

ASCO  /  November 10, 2024

ASCO has announced the participants and mentors selected for its new International Clinical Research Scholars (ICR) program. Eighteen scholars were selected by the ASCO Latin America Regional Council to take part in this 1-year program that pairs clinical research training with mentorship opportunit...

Issues in Oncology

Physician Wellness and Professional Burnout

ASCO  /  November 10, 2024

According to an ASCO-sponsored study of burnout and career satisfaction among U.S. oncologists, 44.7% of surveyed oncologists reported feeling symptoms of burnout. ASCO offers information, practical advice, and member perspectives on how to prevent and manage burnout and prioritize wellness in your ...

Legislation

AMA House of Delegates Adopts ASCO-Sponsored Resolutions on Interpretation of Stark Law and Prior Authorization Costs

ASCO  /  October 25, 2024

On September 23, 2024, the U.S. House of Representatives passed the Seniors’ Access to Critical Medications Act of 2024 (H.R. 5526), which would make permanent a waiver put in place during the COVID-19 pandemic that allowed Medicare patients to receive medications dispensed by in-office pharmacies b...

Issues in Oncology

Cancer Clinical Trials Continue to Be Out of Reach for Many Patients

ASCO  /  October 25, 2024

Millions of Americans with cancer likely struggle to access some of the most advanced, state-of-the-art treatments being tested in clinical trials for their disease, according to a recent analysis from ASCO. The 2023 State of Cancer Care in America Snapshot and corresponding manuscript found 70% of...

Legislation

Cancer Provider Groups Across the Country Urge Congress to Pass Prior Authorization Reform

ASCO  /  October 10, 2024

The Association for Clinical Oncology (ASCO), along with 46 state oncology societies, sent a letter to U.S. House and Senate leadership urging Congress to pass the Improving Seniors’ Timely Access to Care Act (H.R. 8702/S. 4532), which would streamline prior authorization practices within Medicare A...

Lung Cancer

ASCO Updates Stage III NSCLC Guideline to Include Osimertinib in Wake of LAURA Trial Data

Dave Levitan  /  October 10, 2024

ASCO has issued a rapid update to its guideline on the management of stage III non–small cell lung cancer (NSCLC), based on the results of the phase III LAURA trial, which was presented at the 2024 ASCO Annual Meeting and published simultaneously in The New England Journal of Medicine.1,2 The guidel...

ASCO Presents Ethan Basch, MD, MSc, FASCO, With the Joseph Simone Quality Care Award

ASCO  /  September 25, 2024

ASCO will recognize Ethan Basch, MD, MSc, FASCO, a medical oncologist and Distinguished Professor at the University of North Carolina, with the Joseph Simone Quality Care Award and Lecture at the 2024 ASCO Quality Care Symposium. This year’s meeting will be held in San Francisco and online on Sept...

Colorectal Cancer

ASCO Issues First Guideline Specific to Locally Advanced Rectal Cancer

Leah Lawrence  /  September 25, 2024

ASCO has released its first clinical practice guideline focused specifically on the management of locally advanced rectal cancer.1 “Rectal cancer, and especially locally advanced rectal cancer, is a complex disease that requires individualized approaches using multimodality therapies to have the b...

Supportive Care

New Collaborative Guideline Highlights the Importance of Multidisciplinary Care for Patients With Osteoradionecrosis

Emily A. Kuhl, PhD  /  September 10, 2024

A joint guideline from the International Society of Oral Oncology–Multinational Association for Supportive Care in Cancer and ASCO seeks to fill a gap in the clinical guidance for patients with head and neck cancers who develop osteoradionecrosis following their head and neck radiation therapy.1 Des...

Palliative Care

ASCO Guideline Update Highlights the Importance of Early Integration of Palliative Care for Patients With Cancer

Jennifer Cable, PhD  /  August 25, 2024

Growing awareness of the benefits of palliative care in patients with cancer has prompted ASCO to update its recommendations for clinicians, patients, caregivers, and health-care organizations on integrating palliative care in oncology.1 The updated guideline reinforces prior recommendations in the ...

Legislation

SCOTUS Ruling Upends Country’s Regulatory Framework, Threatens to Complicate and Delay Health-Care Delivery

ASCO  /  August 25, 2024

The Association for Clinical Oncology (ASCO) has serious concerns about the impact of the Supreme Court’s rulings in Loper Bright Enterprises v Raimondo and Relentless, Inc. v Department of Commerce on cancer care. These decisions overturned the “Chevron deference” or “Chevron doctrine,” a legal pri...

Supportive Care

Updated ASCO Guidance on Cancer-Related Fatigue Expands Patient Options for Interventions

Maxine Lipner  /  July 25, 2024

A new update to the ASCO guideline on managing cancer-related fatigue recommends that health care providers urge their patients to exercise, as well as use cognitive-behavioral therapy and mindfulness-based programs to help prevent and treat this prevalent symptom.1 It is estimated that between 30% ...

AMA House of Delegates Adopts Record Six ASCO-Led Resolutions

ASCO  /  July 10, 2024

Delegates from the Association for Clinical Oncology (ASCO) participated in the 2024 Annual Meeting of the American Medical Association (AMA) House of Delegates (HOD) on June 7 to 12 in Chicago. ASCO created and was the primary sponsor of six resolutions that the AMA HOD adopted as policy, an Associ...

Issues in Oncology

ASCO Issues New Guidance on Vaccinations for Adults With Cancer

Daniel M. Keller, PhD  /  July 10, 2024

A new ASCO Clinical Practice Guideline recommends several vaccinations (eg, seasonal, herpes zoster, human papillomavirus [HPV], and others) for adults with solid or hematologic malignancies because of heightened infection risks from vaccine-preventable illnesses.1 The guideline covers the essential...

ASCO Sets Six Guiding Principles for AI in Oncology

ASCO  /  June 25, 2024

ASCO has released “Principles for the Responsible Use of Artificial Intelligence in Oncology,” to guide the Society’s consideration of all aspects of artificial intelligence (AI). With this manuscript, ASCO joins colleagues across medicine in offering principles that should be applied in development...

Supportive Care

ASCO Issues New Guidance on Cannabis and Cannabinoid Use in Adults With Cancer

Aaron Tallent  /  June 25, 2024

Many Americans, including patients with cancer, use cannabis and cannabinoids. In response to this reality, ASCO has issued a guideline for clinicians, adults with cancer, caregivers, and researchers on their medical use.1 The recommendations cover all cancer types and address products ranging from ...

Guideline Update Seeks to Aid Clinicians in the Selection of Systemic Treatments for Advanced Hepatocellular Carcinoma

Emily A. Kuhl, PhD  /  June 10, 2024

An ASCO guideline update offers new recommendations on systemic treatment for advanced hepatocellular carcinoma (HCC), based on promising findings from several recent randomized controlled trials as well as the approval of new first- and second-line immunotherapy combinations.1 “This guideline in...

ASCO Congratulates 2024 Special Awards Recipients

ASCO  /  June 3, 2024 - Narratives Special Issue

ASCO and Conquer Cancer, the ASCO Foundation, will recognize researchers, patient advocates, philanthropists, teachers, and global oncology leaders who have reshaped cancer care around the world with the Society’s highest honors at the 2024 ASCO Annual Meeting. The 2024 Special Award Recipients are...

Lung Cancer

ASCO Issues Updated Guidelines for Stage IV NSCLC With and Without Driver Alterations

Brandon May  /  May 25, 2024

ASCO has issued new evidence-based updates to two living guidelines on the treatment of stage IV NSCLC with and without driver alterations.1,2 Updated Recommendations: Stage IV NSCLC With Driver Alterations The most “extensive work” in the updates occurred in the guideline on stage IV NSCLC with d...

Issues in Oncology

New Policy Statement Addresses Social, Economic, and Environmental Factors Influencing Cancer Care, Outcomes

ASCO  /  May 10, 2024

ASCO’s new policy statement highlights the need for formalized efforts to address health-related social needs and outlines ways to address social determinants of health (SDOH) in cancer care. Social determinants are defined as conditions in which people are born, grow, live, work, and age, which ma...

Issues in Oncology

America’s Cancer Doctors Demand Action From Congress: Address Drug Shortages

ASCO  /  May 10, 2024

Cancer doctors from across the United States are lending their voices to a new advocacy campaign to end drug shortages. Led by the Association for Clinical Oncology (ASCO), nearly 500 oncology professionals have signed an open letter to Congress and the administration highlighting the severe impact ...

Pamela Kunz, MD, Named Editor-in-Chief of New JCO Oncology Advances

ASCO  /  April 25, 2024

ASCO recently announced the upcoming launch of JCO Oncology Advances (JCO OA), a new open-access and interdisciplinary journal. Pamela Kunz, MD, will serve as the new Editor-in-Chief of this innovative journal, dedicated to accelerating progress in the global fight against cancer by providing a plat...

Breast Cancer

Rapid Guideline Update Supports Capivasertib for Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer

Emily A. Kuhl, PhD  /  April 25, 2024

Patients with estrogen receptor–positive, HER2-negative metastatic breast cancer now have a new medication option that extends survival, according to an ASCO rapid guideline update.1 The update was designed to orient clinicians to outcomes from the CAPItello-291 trial, which led to the U.S. Food and...

Breast Cancer

ASCO Releases Resource-Stratified Guideline for the Treatment of Metastatic Breast Cancer

Mindy Tanzola, PhD  /  March 25, 2024

ASCO has released a new guideline on the treatment of patients with metastatic breast cancer in resource-constrained settings, where maximal setting–recommended treatments are not available.1 The guideline, designed for clinicians, policymakers, and patients, provides stratified recommendations base...

ASCO Chief Medical Officer Testifies to Congress About Ongoing Cancer Drug Shortage Crisis

ASCO  /  March 10, 2024

On February 6, 2024, Julie R. Gralow, MD, FACP, FASCO, Chief Medical Officer and Executive Vice President of the Association for Clinical Oncology (ASCO), testified before the full House Committee on Ways and Means on the crisis of ongoing cancer drug shortages. More than 15 cancer drugs continue to...

Breast Cancer
Genomics/Genetics

ASCO and SSO Publish New Guideline on Germline Testing in Breast Cancer

Brandon May  /  March 10, 2024

ASCO in partnership with the Society of Surgical Oncology (SSO) has released a new guideline addressing recommendations in germline testing in patients with breast cancer.1 The guideline provides oncologists with a framework for how to approach germline testing and recommendations for who should be ...

Prostate Cancer

Rapid Guideline Update on Radiotracers for Determining Radioligand Treatment Eligibility in Metastatic Castration-Resistant Prostate Cancer

Brandon May  /  February 25, 2024

ASCO has released a guideline rapid recommendation update addressing radiotracers used for prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) diagnostic imaging for selecting patients with metastatic castration-resistant prostate cancer (mCRPC) to receive lutetium-177–label...

Issues in Oncology

ASCO Welcomes New Rule Establishing Electronic Prior Authorization in Federal Health Plans

ASCO  /  February 25, 2024

On January 17, the Centers for Medicare & Medicaid Services (CMS) issued its rule requiring federal health plans—including Medicare Advantage plans, Medicaid plans, and Qualified Health Plans (QHP) on Federally Facilitated Exchanges (FFEs)—to establish an electronic prior authorization process t...

Eric J. Small, MD, FASCO, Elected ASCO President for 2025–2026 Term

The ASCO Post Staff  /  January 25, 2024

ASCO has elected Eric J. Small, MD, FASCO, to lead as its President beginning in June 2025. Dr. Small, a long-time ASCO member and volunteer, will take office as President-Elect immediately following the ASCO Annual Business Meeting in Chicago on June 3, 2025. An additional six ASCO members were ele...

2023 ASCO Advocacy Highlights

ASCO  /  January 25, 2024

The Association for Clinical Oncology (ASCO) had an immensely impactful year of advocacy work, which is possible only with guidance and passion from our members. In partnership with the ASCO’s Government Relations Committee, five advocacy priorities were identified for the year: Protecting patien...

Lung Cancer

ASCO and Ontario Health Publish New Recommendations for Systemic Therapy in SCLC

Brandon May  /  December 25, 2023

A newly published guideline update from ASCO and Ontario Health provides evidence-based recommendations on the use of systemic therapy for small cell lung cancer (SCLC).1 Recommendations cover where novel agents fit in the treatment landscape, the management of disease in older patients with limited...

Neuroendocrine Tumors

New Guideline Offers Much-Needed Support in the Treatment of Neuroendocrine Tumors

Emily A. Kuhl, PhD  /  December 10, 2023

An ASCO guideline has been developed to inform the use of systemic treatments for metastatic, well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs).1 The guideline helps fill a knowledge gap among community oncologists in particular, who typically do not see many of these rare ...

Issues in Oncology

The Progress of Delivering High-Quality Cancer Care Takes Center Stage at Workshop

ASCO  /  November 25, 2023

ASCO and the National Cancer Policy Forum cohosted a workshop on October 5–6, 2023, to mark the 10-year anniversary of the Institute of Medicine (IOM) consensus report, Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis.1 The National Cancer Policy Forum is a convenin...

Kidney Cancer

ASCO Rapid Recommendation Update Cautions Against Triplet Therapy for Metastatic Clear Cell RCC

Emily A. Kuhl, PhD  /  November 25, 2023

An ASCO Rapid Recommendation Update advises oncologists to avoid the use of triple combination therapy for the management of metastatic clear cell renal cell carcinoma (RCC).1 The new guidance, which updates recommendations from the original 2022 guideline, reflects findings from a phase III, double...

Issues in Oncology

Association Urges Congress to Prioritize Childhood Cancer Funding, Research

ASCO  /  November 10, 2023

In honor of Childhood Cancer Awareness Month, the Association for Clinical Oncology (ASCO) joined with 25 stakeholders for a series of advocacy activities in Washington, DC, during the week of September 18. During meetings with lawmakers on September 20, ASCO and the Alliance for Childhood Cancer u...

Issues in Oncology

CMS, Congress Must Work Together to Support Access to Cancer Care and Physician Practice Health

ASCO  /  October 25, 2023

In letters to the Centers for Medicare & Medicaid Services (CMS), the Association for Clinical Oncology (ASCO) commented on provisions that impact cancer care for Medicare beneficiaries in the 2024 Medicare Physician Fee Schedule (MPFS) and Quality Payment Program (QPP) proposed rule, as well as...

Issues in Oncology

ASCO Response to Drug Shortages Request for Information

ASCO  /  October 25, 2023

The Association for Clinical Oncology (ASCO) responded to a bicameral Request for Information (RFI) on the underlying factors driving drug shortages. The Association’s comments highlighted the impact of the shortages on patient care and pointed to economic failures and supply chain vulnerabilities t...

Skin Cancer

Guideline Update Reflects Recent Surge of New Data in Systemic Therapy for Melanoma

Emily A. Kuhl, PhD  /  October 10, 2023

A guideline update on systemic treatment for melanoma offers new guidance in several areas, including the selection of front-line therapy for patients with metastatic disease with and without BRAF mutations, treatment of patients with earlier-stage disease in the adjuvant setting, and emerging neoad...

ASCO and State Affiliates Wrap Up Successful State Sessions

ASCO  /  October 10, 2023

After a fast-paced first half of the year, most state legislatures across the 50 states and Washington, DC, have adjourned for the year. The Association for Clinical Oncology (ASCO) and State Affiliates successfully collaborated to advance many shared 2023 state advocacy priorities, including those ...

Integrative Oncology

SIO and ASCO Partner to Develop Integrative Oncology Care Recommendations for Anxiety and Depression in Patients With Cancer

Mindy Tanzola  /  September 25, 2023

The Society for Integrative Oncology (SIO) and ASCO have partnered to develop a new guideline on integrative oncology care of symptoms of anxiety and depression in adults with cancer. The guideline reviews the evidence for a range of integrative approaches, including mindfulness-based interventions,...

ASCO Participates in President’s Cancer Panel

ASCO  /  September 25, 2023

ASCO joined the President’s Cancer Panel on September 7, 2023, to highlight the numerous ways ASCO is working to advance the National Cancer Plan and achieve President Biden’s Cancer Moonshot goal of “ending cancer as we know it.” This all-day, virtual event was the first public meeting in support ...

Issues in Oncology
Solid Tumors

ASCO Releases Rapid Recommendation Update on Use of Olanzapine to Treat Cancer-Related Cachexia

LEAH LAWRENCE  /  September 25, 2023

ASCO recently released a new rapid recommendation update that addresses the use of olanzapine to treat cancer-related cachexia, a topic originally addressed in its 2020 guideline on the management of cancer cachexia in adults with advanced cancer.1,2 At that time, there was insufficient evidence to ...

Geriatric Oncology

ASCO Updates Guideline on Assessment, Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy

Brandon May  /  September 10, 2023

ASCO has updated a guideline on the practical assessment and management of age-associated vulnerabilities in older patients receiving systemic cancer therapy.1 Among the updates, the guideline adds more detail to domains that should be evaluated in geriatric assessments (GAs) and expands patient pop...

Breast Cancer

ASCO Awarded $11 Million to Study Oral Drug Dosing Strategies in Older Adults With Metastatic Breast Cancer Receiving CDK4/6 Inhibitors

ASCO  /  August 10, 2023

ASCO has been awarded $11 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI) to study dosing strategies of oral CDK4/6 inhibitors in older adults living with metastatic breast cancer. The study aims to address a critical evidence gap in the treatment of this dise...

Lung Cancer

Rapid Guideline Update Offers Key Evidence-Based Recommendations for Stage III NSCLC Management

Brandon May  /  August 25, 2023

A new ASCO guideline rapid update provides updated recommendations for the management of stage III non–small cell lung cancer (NSCLC). These updated recommendations made by the ASCO expert panel cover treatment options for patients with resected disease and specific genetic mutations as well as ther...

Issues in Oncology

Cancer Care Providers Applaud New Federal Rule Regulating Short-Term Limited Duration Plans

ASCO  /  August 10, 2023

On July 7, 2023, the Department of Health and Human Services (HHS), Department of Labor, and the Treasury Department issued a proposed rule regulating the availability of short-term limited duration insurance plans. The rule would restrict the availability of these plans to no more than 4 months. ...

ASCO Issues Statements on Recent U.S. Supreme Court Rulings on Affirmative Action, LGBTQ+ Rights

ASCO  /  July 25, 2023

ASCO issued a statement regarding the U.S. Supreme Court decision on affirmative action on June 29. A statement from ASCO Chief Executive Officer, Clifford A. Hudis, MD, FASCO, FACP, follows: “[The] U.S. Supreme Court ruling on affirmative action threatens to reverse hard-won gains in diversity acr...

ASCO Blueprint Report Captures Steady Progress Toward Equity, Diversity, and Inclusion

ASCO  /  July 25, 2023

The American Society of Clinical Oncology (ASCO) has released its first-ever Equity, Diversity, and Inclusion (EDI) Blueprint Report, highlighting ASCO’s 2022 advancements in the EDI space. The report provides information on 22 initiatives that ASCO launched across the mission pillars of research, ...

Advertisement

Advertisement




Advertisement